Health & Personal Care
HIGH
FDA DRUG
Endo USA Recalls 1,041 Cartons of Everolimus 5mg Tablets Over IP-C Impurity (2025)
Endo USA, Inc. recalled 1,041 cartons of Everolimus 5mg tablets nationwide in the United States due to an impurity IP-C out of specification. The impurity IP-C is out of specification in the drug product. Patients and healthcare providers should stop using this product immediately and contact Endo USA or their healthcare provider for guidance.
Everolimus
Failed Impurities/Degradation